Laboratory Corporation of America Holdings (NYSE:LH)

217.93
Delayed Data
As of Jun 06
 +0.01 / +0.00%
Today’s Change
200.32
Today|||52-Week Range
263.13
-7.45%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$19.2B

Company Description

Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC.

Contact Information

Laboratory Corp. of America Holdings
358 South Main Street
Burlington North Carolina 27215-5837
P:(336) 229-1127
Investor Relations:
(336) 436-5076

Employees

Shareholders

Mutual fund holders50.93%
Other institutional41.09%
Individual stakeholders1.65%

Top Executives

Adam H. SchechterChairman, President & Chief Executive Officer
Mark S. SchroederCOO, Executive VP & President-Diagnostics
Glenn Andrew EisenbergChief Financial Officer & Executive Vice President
Lance V. BerberianChief Information & Technology Officer & EVP
Brian J. CaveneyExecutive VP, Chief Medical & Scientific Officer